Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 70/100

Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Wednesday, January 3, 2024 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that its president and CEO, Raul Rodriguez, will deliver a company overview at the 42nd Annual J.P. Morgan Healthcare Conference. This event is scheduled for January 11, 2024, in San Francisco, CA. The conference presents a platform for Rigel to showcase its advancements in therapies for hematologic disorders and cancer, aligning with its mission to improve patient outcomes. Interested parties can access the presentation through the company's Investor Relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is participating in a prominent healthcare conference.
  • The presentation offers the opportunity to highlight the company's therapies and pipeline.
  • Raul Rodriguez will provide an overview, potentially increasing investor interest.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Jan. 3, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 p.m. PT in San Francisco, CA.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Investors & Media Contacts:
Rigel Pharmaceuticals, Inc.
Email: [email protected]
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When is Rigel Pharmaceuticals' presentation at the JPM Conference?

Rigel Pharmaceuticals will present on January 11, 2024, at 12:00 p.m. PT.

How can I access Rigel's presentation webcast?

You can access the webcast on Rigel's Investor Relations section at www.rigel.com.

What does Rigel Pharmaceuticals focus on?

Rigel Pharmaceuticals focuses on developing therapies for hematologic disorders and cancer.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Tags: RIGL Viatris Investor Conferences Healthcare Raul Rodriguez J.P. Morgan Healthcare Conference biotechnology hematologic disorders
Last updated: Jan 3, 2024